• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amicus Therapeutics, Inc. - Common Stock (NQ:FOLD)

    14.30 -0.01 (-0.03%)
    Streaming Delayed Price Updated: 11:12 AM EST, Feb 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Amicus Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    News headline image
    Amicus Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022
    From Amicus Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Amicus Therapeutics Announces Participation at World Muscle Society 2022
    From Amicus Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know ↗
    Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the... 
    Via Benzinga
    News headline image
    Amicus Shares Encouraging Long-Term Data Of AT-GAA Study In Pompe Disease ↗
    Amicus Therapeutics Inc (NASDAQ: FOLD) has  
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗
    Upgrades 
    Via Benzinga
    News headline image
    Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know ↗
    After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar. 
    Via Benzinga
    News headline image
    iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday ↗
    U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. 
    Via Benzinga
    News headline image
    This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket ↗
    Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday. 
    Via Benzinga
    News headline image
    Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗
    Gainers 
    Via Benzinga
    News headline image
    PayPal, SoFi Technologies And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
      PayPal Holdings, Inc. (NASDAQ: PYPL) rose 12% to $100.35 in pre-market trading after the company reported better-than-expected Q2 results and raised FY22 EPS guidance. 
    Via Benzinga
    News headline image
    Biotech Investors: August's Key PDUFA Catalysts You Must Know ↗
    Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to be positive. That said, none of the drugs approved during the... 
    Via Benzinga
    News headline image
    Short Volatility Alert: Amicus Therapeutics, Inc. ↗
    On Tuesday, shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) experienced volatile short activity. After the activity, the stock price went up +5.67% to $9.88. The overall... 
    Via Benzinga
    News headline image
    Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates ↗
    May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    News headline image
    7 Biotech Stocks With Key Catalysts for May ↗
    The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns. 
    Via InvestorPlace
    News headline image
    FDA Extends Review Of Amicus Therapeutics' AT-GAA For The Treatment Of Pompe Disease By Three Months ↗
    The U.S. 
    Via Benzinga
    News headline image
    Recap: Amicus Therapeutics Q1 Earnings ↗
    Amicus Therapeutics (NASDAQ:FOLD) reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    News headline image
    Earnings Outlook For Amicus Therapeutics ↗
    Amicus Therapeutics (NASDAQ:FOLD) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Amicus... 
    Via Benzinga
    News headline image
    Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗
    The month of April was a mixed one for regulatory approvals. The Food and Drug Administration delayed approvals for at least three treatment candidates. New molecular entity, or NME, approvals, a... 
    Via Benzinga
    News headline image
    Amicus Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗
    Amicus Therapeutics (NASDAQ:FOLD) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results. 
    Via Benzinga
    News headline image
    Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall ↗
    Amicus Therapeutics Inc (NASDAQ: FOLD) has terminated its plans to spin off its gene therapy assets, citing 'existing market conditions.' With "market... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (... 
    Via Benzinga
    News headline image
    Amicus Therapeutics Earnings Preview ↗
    Amicus Therapeutics (NASDAQ:FOLD) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts... 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2022 ↗
    Upgrades According to Seaport Global, the prior rating for Lennar Corp (NYSE: 
    Via Benzinga
    News headline image
    10 Biggest Price Target Changes For Friday ↗
    Keybanc cut Robinhood Markets, Inc. (NASDAQ:HOOD... 
    Via Benzinga
    News headline image
    60 Biggest Movers From Yesterday ↗
    Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company... 
    Via Benzinga
    News headline image
    Mid-Afternoon Market Update: Dow Tumbles 250 Points; Zynga Shares Spike Higher ↗
    Toward the end of trading Monday, the Dow traded down 0.70% to 35,978 while the NASDAQ fell 0.93% to 14,796.51. The S&P also fell, dropping, 0.72% to 4,643.29. The U.S.... 
    Via Benzinga
    News headline image
    Mid-Day Market Update: Nasdaq Dips 300 Points; Apria Shares Surge ↗
    Midway through trading Monday, the Dow traded down 1.23% to 35,787.07 while the NASDAQ fell 2.07% to 14,627.21. The S&P also fell, dropping, 1.52% to 4,605.95. The U.S. has... 
    Via Benzinga
    News headline image
    45 Stocks Moving In Monday's Mid-Day Session ↗
    Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88. Zynga Inc. (NASDAQ: ZNGA) gained 45.7% to $8.74 after the company announced it will be acquired... 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021 ↗
    Upgrades For Targa Resources Corp (NYSE: 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.